EVOKE+ demonstrated favorable shifts in Alzheimers-related biomarkers, including markers of neurodegeneration and inflammation [24]
Not that this has not been demonstrated before but to my surprise the questions on thyroid tumors and GLP-1 RA keep coming especially from non-endocrinologists This was a huge study that included a total of 460,032 users of GLP-1RAs, 717,792 users of SGLT2is, 2,055,583 users of DPP-4is, and 1,119,868 users of SUs GLP-1RA exposure was not associated with an increased risk of thyroid tumors compared with SGLT2is, DPP-4is, or SUs (meta-analysis: GLP-1RA vs
The major outcome included effects on cognitive function before and after the use of GLP-1 receptor agonists (Figure 4)
GLP-1 receptor agonists such as semaglutide (marketed as Ozempic and Wegovy) and dual GIP/GLP-1 agonist tirzepatide (Mounjaro) have become increasingly popular for weight loss in both women and men
Tracking your progress not only helps your healthcare provider fine-tune your treatment but also gives you those encouraging reminders of how far you've come
HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding
